A new pill, Orforglipron, is set to revolutionize weight loss and diabetes treatment. This daily pill, developed by Eli Lilly, has shown significant weight reduction in early trials. It offers a needle-free alternative to current injectables like Ozempic and Mounjaro. This development could offer a comprehensive solution for patients managing both Type 2 diabetes and obesity, pending FDA approval.
